ARCHIVES

Aromasin Approved By FDA For ER+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Specific Pathology Pattern Can Predict Recurrence

August 30, 2013

FDA Issues MedWatch Warning, Begins Safety Review Of Prostate Cancer Drugs

May 7, 2010

Strict Regulation Of Tobacco Products Proposed in Senate

November 24, 1989

NCI spends A Third Of Its Budget On Prevention

May 15, 1992

Program Project Guidelines Available

October 27, 1995

Announcement, RFA On Drug Discovery Groups Coming

December 10, 1982